HEMATOLOGICAL MALIGNANCIES
Clinical trials for HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug shows promise for Hard-to-Treat blood cancer
Disease control Recruiting nowThis study tests a new drug called talquetamab in people with multiple myeloma, a type of blood cancer, that has returned or stopped responding to other treatments. The drug is designed to help the immune system attack cancer cells. About 510 participants will receive the drug to…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Massive study seeks genetic clues to stop blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find genetic changes that cause early blood conditions to turn into cancer. Researchers will collect blood, bone marrow, or cheek swab samples from up to 10,000 people who have or are at risk for certain blood cancers. The goal is to better understand how these…
Matched conditions: HEMATOLOGICAL MALIGNANCIES
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC